This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
An overview of harms associated with β-lactam antimicrobials: where do the carbapenems fit in?
-
Correspondence: Robert C Owens owensr@mmc.org owensr@mmc.org
Critical Care 2008, 12(Suppl 4):S3 doi:10.1186/cc6819
Accesses
- Last 30 days: 237 accesses
- Last 365 days: 2529 accesses
- All time: 10637 accesses
Cited by
BioMed Central: 1 citation
|
Introduction
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance Reuben Ramphal Critical Care 2008, 12(Suppl 4):S1 (21 May 2008) |
